{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "esgPopulated": false, "market": "se_market", "longName": "Lipum AB (publ)", "marketState": "REGULAR", "regularMarketPrice": 10.75, "messageBoardId": "finmb_330107839", "exchange": "STO", "shortName": "Lipum AB", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Stockholm", "regularMarketChangePercent": 0.0, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 2.9899998, "fiftyTwoWeekLowChangePercent": 0.38530925, "fiftyTwoWeekRange": "7.76 - 24.4", "fiftyTwoWeekHighChange": -13.65, "fiftyTwoWeekHighChangePercent": -0.55942625, "fiftyTwoWeekLow": 7.76, "fiftyTwoWeekHigh": 24.4, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -5.94, "firstTradeDateMilliseconds": 1619074800000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1683901004, "regularMarketDayHigh": 10.75, "regularMarketDayRange": "10.75 - 10.75", "regularMarketDayLow": 10.75, "regularMarketVolume": 36, "regularMarketPreviousClose": 10.75, "bid": 10.1, "ask": 10.75, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 10.1, "averageDailyVolume3Month": 4988, "averageDailyVolume10Day": 554, "sharesOutstanding": 7654220, "bookValue": 3.664, "fiftyDayAverage": 11.4122, "fiftyDayAverageChange": -0.6622, "fiftyDayAverageChangePercent": -0.05802562, "twoHundredDayAverage": 14.0913, "twoHundredDayAverageChange": -3.3413, "twoHundredDayAverageChangePercent": -0.23711793, "marketCap": 83041280, "priceToBook": 2.9339519, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "symbol": "LIPUM.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "TvistevAegen 48C", "city": "Ume\u00e5", "zip": "907 36", "country": "Sweden", "phone": "46 9 03 40 34 30", "website": "https://www.lipum.se", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116. The company was incorporated in 2010 and is based in Ume\u00e5, Sweden.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Prof. Olle  Hernell", "age": 77, "title": "Co-Founder & Director", "yearBorn": 1945, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marina  Norberg", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Einar  Ponten", "age": 61, "title": "Chief Exec. Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Associate Prof. Susanne  Lindquist", "age": 62, "title": "Co-Founder & Head of Research (CSO)", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pernilla  Abrahamsson", "age": 50, "title": "Chief Operating Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}